| Financial Year |
March 31 2023 |
| Monetary Funds |
1,438,566,809.60 |
| Held-for-trading Financial Assets |
65,270,880.83 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,153,497,653.09 |
| Advances to Suppliers |
222,694,313.76 |
| Other Receivables |
67,786,735.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,433,704,069.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,795,649,168.31 |
| Total Current Assets |
7,236,331,000.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
400,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
2,157,406,710.63 |
| Under-construction Projects |
18,196,640.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
246,306,611.06 |
| R&D expenses |
1,859,951.64 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,926,398.14 |
| Deferred Income Tax Assets |
10,024,380.37 |
| Other Non-Current Assets |
10,230,678.00 |
| Sub-Total of Non-Current Assets |
2,883,175,768.18 |
| Total Assets |
10,119,506,768.44 |
| Short-Term Loans |
12,017,688.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,224,650,027.03 |
| Accounts Payable |
429,739,958.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
50,583,071.26 |
| Taxes Payable |
75,296,248.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
359,998,430.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,485,197.88 |
| Other Current Liabilities |
53,866,375.92 |
| Sub-Total of Current Liabilities |
2,763,096,158.43 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
46,998,743.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
258,180,328.66 |
| Total Liabilities |
3,021,276,487.09 |
| Paid-In Capital(Or Share Stock) |
1,479,416,553.00 |
| Capital Surplus |
3,360,132,288.58 |
| Surplus Reserve |
135,483,580.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,070,642,221.37 |
| Minority Stockholder's Interest |
3,928,343.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,094,301,937.63 |
| Owner's Equity（Stockholder's Equity） |
7,098,230,281.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,119,506,768.44 |
